It took 27 years, but Cytokinetics secured its first U.S. drug approval. On Friday, the Food and Drug Administration cleared ...

Discover how intellectual property rights protect exclusive pharmaceutical use and brand names in biotechnology, influencing innovation and market dynamics.

Lixte Biotechnology Holdings ( ($LIXT) ) has shared an announcement. On December 18, 2025, Lixte Biotechnology Holdings, Inc. entered into ...

Danaher Corporation DHR has been benefiting from strength in its Biotechnology segment. In the third quarter of 2025, the ...

Norgine, a leading European specialty pharmaceutical company, today announced an exclusive licensing agreement under which ...

Microbial biotechnology is a dynamic field, The origins of microbiology can be traced back to the pioneering research by scientists such as Louis Pasteur and Robert Koch in the 19 th century. Within a ...

Cathie Wood’s ARK Investment Management sharply increased its exposure to AI-driven biotechnology and cryptocurrency during ...

Biotechnology is a curious marriage of two seemingly disparate worlds. On one end, we have living organisms—wild, unpredictable celestial creations that can probably never be understood or appreciated ...

As of Tuesday, December 02, Vir Biotechnology, Inc.’s VIR share price has dipped by 8.57%, which has investors questioning if this is right time to buy.

A catalyst for technology-based economic development in life sciences . In 1984, three of North Carolina’s largest ...

Learn more about whether Legend Biotech Corporation or Zymeworks Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.